Research

NICE has issued a new position statement regarding the use of the EQ-5D-5L value set in evidence submitted to its HTA process.

OHE has published a response to the critique of the EQ-5D-5L value set for England study.

OHE staff recently attended the ISPOR Europe conference in Barcelona. In this blog post, we share a selection of our presentations.

OHE has published its report to the Charity Commission for the year 2017, its first full year as a registered charity.

Meet some of the OHE team at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2018 conference in Barcelona, 10-14 November.

OHE presented at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare, held October 2018.

OHE contributed to the organisation and scientific content of the recent EuroQol Plenary Meeting in Lisbon, Portugal.

OHE’s Professor Nancy Devlin will be leaving OHE to take up a new role at the University of Melbourne, Australia, from January 2019.

Nancy will be Professor of Health Economics and Director of the Centre of Health Policy in the Melbourne School of Population and Global Health. The Centre of Health Policy comprises research units in Demography and Ageing; Evaluation and Implementation Science; Public Health and Law; Cancer Health Services Research; and Health Economics (the latter of which Nancy will also lead).

UK Research and Innovation has awarded OHE a grant as a partner in a national research network for student mental health.

When should progression-free survival be used as a surrogate for overall survival in oncology? Uneven reporting of results – different definitions and methods of analysis, lack of rigour in applying methodology – make progress difficult.